APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prenatal Screening

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Prenatal Screening Market Outlook and Growth Opportunities 2026

11 April 2026Not stated

Choose your research edition.

Industry ResearchPrenatal Screening Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Prenatal Screening Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Prenatal Screening Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prenatal Screening Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Prenatal Screening Market Analysis and Forecast 2026-2032180 pages · $4,950 USD

Market perspective

The global Prenatal Screening market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Prenatal Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prenatal Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prenatal Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Prenatal Screening market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Prenatal Screening market include Thermo Fisher Scientific, Revvity, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB and Veritas Genetics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Prenatal Screening market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prenatal Screening and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prenatal Screening revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Prenatal Screening market.

Prenatal Screening Segment by Company

Thermo Fisher Scientific

Revvity

Quest Diagnostics

MedGenome

Mayo Clinic Laboratories

GeneDx

PreventionGenetics

SYNLAB

Veritas Genetics

GGA

Cordlife

Rainbow Genomics

BGI Genomics

Berry Genomics

Annaroad

Jiajian Medical Testing

Genesky

Weihansi Biomedical Technology

Prenatal Screening Segment by Type

Serum Biomarker Screening

Ultrasonographic Imaging Screening

Others

Prenatal Screening Segment by Application

Public Hospitals

Private Hospitals

Prenatal Screening Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Prenatal Screening status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Prenatal Screening key companies, revenue, market share, and recent developments.

3. To split the Prenatal Screening breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Prenatal Screening market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Prenatal Screening significant trends, drivers, influence factors in global and regions.

6. To analyze Prenatal Screening competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prenatal Screening market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prenatal Screening and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prenatal Screening.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prenatal Screening industry.

Chapter 3: Detailed analysis of Prenatal Screening company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Prenatal Screening in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Prenatal Screening in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Prenatal Screening Industry Trends Table 2. Prenatal Screening Industry Drivers Table 3. Prenatal Screening Industry Opportunities and Challenges Table 4. Prenatal Screening Industry Restraints Table 5. Global Prenatal Screening Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Prenatal Screening Revenue Share by Company (2021-2026) Table 7. Global Prenatal Screening Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Prenatal Screening Key Company Manufacturing Base & Headquarters Table 9. Global Prenatal Screening Company, Product Type & Application Table 10. Global Prenatal Screening Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Prenatal Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Serum Biomarker Screening Table 15. Significant Companies of Ultrasonographic Imaging Screening Table 16. Significant Companies of Others Table 17. Global Prenatal Screening Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Prenatal Screening Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Prenatal Screening Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Prenatal Screening Sales Value Share by Type (2021-2026) Table 21. Global Prenatal Screening Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Public Hospitals Table 23. Significant Companies of Private Hospitals Table 24. Global Prenatal Screening Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Prenatal Screening Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Prenatal Screening Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Prenatal Screening Sales Value Share by Application (2021-2026) Table 28. Global Prenatal Screening Sales Value Share by Application (2027-2032) Table 29. Global Prenatal Screening Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Prenatal Screening Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Prenatal Screening Sales Value Share by Region (2021-2026) Table 32. Global Prenatal Screening Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Prenatal Screening Sales Value Share by Region (2027-2032) Table 34. Global Prenatal Screening Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Prenatal Screening Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Prenatal Screening Sales Value Market Share by Country (2021-2026) Table 37. Global Prenatal Screening Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Prenatal Screening Sales Value Market Share by Country (2027-2032) Table 39. Thermo Fisher Scientific Company Information Table 40. Thermo Fisher Scientific Business Overview Table 41. Thermo Fisher Scientific Prenatal Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Thermo Fisher Scientific Prenatal Screening Product Portfolio Table 43. Thermo Fisher Scientific Recent Development Table 44. Revvity Company Information Table 45. Revvity Business Overview Table 46. Revvity Prenatal Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Revvity Prenatal Screening Product Portfolio Table 48. Revvity Recent Development Table 49. Quest Diagnostics Company Information Table 50. Quest Diagnostics Business Overview Table 51. Quest Diagnostics Prenatal Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Quest Diagnostics Prenatal Screening Product Portfolio Table 53. Quest Diagnostics Recent Development Table 54. MedGenome Company Information Table 55. MedGenome Business Overview Table 56. MedGenome Prenatal Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. MedGenome Prenatal Screening Product Portfolio Table 58. MedGenome Recent Development Table 59. Mayo Clinic Laboratories Company Information Table 60. Mayo Clinic Laboratories Business Overview Table 61. Mayo Clinic Laboratories Prenatal Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Mayo Clinic Laboratories Prenatal Screening Product Portfolio Table 63. Mayo Clinic Laboratories Recent Development Table 64. GeneDx Company Information Table 65. GeneDx Business Overview Table 66. GeneDx Prenatal Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. GeneDx Prenatal Screening Product Portfolio Table 68. GeneDx Recent Development Table 69. PreventionGenetics Company Information Table 70. PreventionGenetics Business Overview Table 71. PreventionGenetics Prenatal Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. PreventionGenetics Prenatal Screening Product Portfolio Table 73. PreventionGenetics Recent Development Table 74. SYNLAB Company Information Table 75. SYNLAB Business Overview Table 76. SYNLAB Prenatal Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. SYNLAB Prenatal Screening Product Portfolio Table 78. SYNLAB Recent Development Table 79. Veritas Genetics Company Information Table 80. Veritas Genetics Business Overview Table 81. Veritas Genetics Prenatal Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Veritas Genetics Prenatal Screening Product Portfolio Table 83. Veritas Genetics Recent Development Table 84. GGA Company Information Table 85. GGA Business Overview Table 86. GGA Prenatal Screening Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. GGA Prenatal Screening Product Portfolio Table 88. GGA Recent Development Table 89. Cordlife Company Information Table 90. Cordlife Business Overview Table 91. Cordlife Prenatal Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Cordlife Prenatal Screening Product Portfolio Table 93. Cordlife Recent Development Table 94. Rainbow Genomics Company Information Table 95. Rainbow Genomics Business Overview Table 96. Rainbow Genomics Prenatal Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Rainbow Genomics Prenatal Screening Product Portfolio Table 98. Rainbow Genomics Recent Development Table 99. BGI Genomics Company Information Table 100. BGI Genomics Business Overview Table 101. BGI Genomics Prenatal Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. BGI Genomics Prenatal Screening Product Portfolio Table 103. BGI Genomics Recent Development Table 104. Berry Genomics Company Information Table 105. Berry Genomics Business Overview Table 106. Berry Genomics Prenatal Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Berry Genomics Prenatal Screening Product Portfolio Table 108. Berry Genomics Recent Development Table 109. Annaroad Company Information Table 110. Annaroad Business Overview Table 111. Annaroad Prenatal Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Annaroad Prenatal Screening Product Portfolio Table 113. Annaroad Recent Development Table 114. Jiajian Medical Testing Company Information Table 115. Jiajian Medical Testing Business Overview Table 116. Jiajian Medical Testing Prenatal Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Jiajian Medical Testing Prenatal Screening Product Portfolio Table 118. Jiajian Medical Testing Recent Development Table 119. Genesky Company Information Table 120. Genesky Business Overview Table 121. Genesky Prenatal Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Genesky Prenatal Screening Product Portfolio Table 123. Genesky Recent Development Table 124. Weihansi Biomedical Technology Company Information Table 125. Weihansi Biomedical Technology Business Overview Table 126. Weihansi Biomedical Technology Prenatal Screening Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Weihansi Biomedical Technology Prenatal Screening Product Portfolio Table 128. Weihansi Biomedical Technology Recent Development Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Prenatal Screening Product Image Figure 2. Global Prenatal Screening Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prenatal Screening Market Size (2021-2032) & (US$ Million) Figure 4. Global Prenatal Screening Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Serum Biomarker Screening Image Figure 8. Ultrasonographic Imaging Screening Image Figure 9. Others Image Figure 10. Global Prenatal Screening Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Prenatal Screening Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Prenatal Screening Sales Value Share by Type (2021-2032) Figure 13. Public Hospitals Image Figure 14. Private Hospitals Image Figure 15. Global Prenatal Screening Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Prenatal Screening Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Prenatal Screening Sales Value Share by Application (2021-2032) Figure 18. Global Prenatal Screening Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Prenatal Screening Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Prenatal Screening Sales Value (2021-2032) & (US$ Million) Figure 21. North America Prenatal Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Prenatal Screening Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Prenatal Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Prenatal Screening Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Prenatal Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Prenatal Screening Sales Value (2021-2032) & (US$ Million) Figure 27. South America Prenatal Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Prenatal Screening Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Prenatal Screening Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Prenatal Screening Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Prenatal Screening Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Prenatal Screening Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Serum Biomarker Screening
  • Ultrasonographic Imaging Screening
  • Others
Applications
  • Public Hospitals
  • Private Hospitals
Companies covered
  • Thermo Fisher Scientific
  • Revvity
  • Quest Diagnostics
  • MedGenome
  • Mayo Clinic Laboratories
  • GeneDx
  • PreventionGenetics
  • SYNLAB
  • Veritas Genetics
  • GGA
  • Cordlife
  • Rainbow Genomics
  • BGI Genomics
  • Berry Genomics
  • Annaroad
  • Jiajian Medical Testing
  • Genesky
  • Weihansi Biomedical Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Prenatal Screening Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Prenatal Screening Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Prenatal Screening Market Dynamics
  1. 2.1 Prenatal Screening Industry Trends
  2. 2.2 Prenatal Screening Industry Drivers
  3. 2.3 Prenatal Screening Industry Opportunities and Challenges
  4. 2.4 Prenatal Screening Industry Restraints
3 Prenatal Screening Market by Company
  1. 3.1 Global Prenatal Screening Company Revenue Ranking in 2025
  2. 3.2 Global Prenatal Screening Revenue by Company (2021-2026)
  3. 3.3 Global Prenatal Screening Company Ranking (2024-2026)
  4. 3.4 Global Prenatal Screening Company Manufacturing Base and Headquarters
  5. 3.5 Global Prenatal Screening Company Product Type and Application
  6. 3.6 Global Prenatal Screening Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Prenatal Screening Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Prenatal Screening Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Prenatal Screening Market by Type
  1. 4.1 Prenatal Screening Type Introduction
  2. 4.1.1 Serum Biomarker Screening
  3. 4.1.2 Ultrasonographic Imaging Screening
  4. 4.1.3 Others
  5. 4.2 Global Prenatal Screening Sales Value by Type
  6. 4.2.1 Global Prenatal Screening Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Prenatal Screening Sales Value by Type (2021-2032)
  8. 4.2.3 Global Prenatal Screening Sales Value Share by Type (2021-2032)
5 Prenatal Screening Market by Application
  1. 5.1 Prenatal Screening Application Introduction
  2. 5.1.1 Public Hospitals
  3. 5.1.2 Private Hospitals
  4. 5.2 Global Prenatal Screening Sales Value by Application
  5. 5.2.1 Global Prenatal Screening Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Prenatal Screening Sales Value by Application (2021-2032)
  7. 5.2.3 Global Prenatal Screening Sales Value Share by Application (2021-2032)
6 Prenatal Screening Regional Value Analysis
  1. 6.1 Global Prenatal Screening Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prenatal Screening Sales Value by Region (2021-2032)
  3. 6.2.1 Global Prenatal Screening Sales Value by Region: 2021-2026
  4. 6.2.2 Global Prenatal Screening Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Prenatal Screening Sales Value (2021-2032)
  7. 6.3.2 North America Prenatal Screening Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Prenatal Screening Sales Value (2021-2032)
  10. 6.4.2 Europe Prenatal Screening Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Prenatal Screening Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Prenatal Screening Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Prenatal Screening Sales Value (2021-2032)
  16. 6.6.2 South America Prenatal Screening Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Prenatal Screening Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Prenatal Screening Sales Value Share by Country, 2025 VS 2032
7 Prenatal Screening Country-level Value Analysis
  1. 7.1 Global Prenatal Screening Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Prenatal Screening Sales Value by Country (2021-2032)
  3. 7.2.1 Global Prenatal Screening Sales Value by Country (2021-2026)
  4. 7.2.2 Global Prenatal Screening Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Prenatal Screening Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Prenatal Screening Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Prenatal Screening Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Prenatal Screening Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Prenatal Screening Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Prenatal Screening Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Prenatal Screening Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Prenatal Screening Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Prenatal Screening Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Prenatal Screening Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Prenatal Screening Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Prenatal Screening Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Prenatal Screening Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Prenatal Screening Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Prenatal Screening Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Prenatal Screening Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Prenatal Screening Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Prenatal Screening Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Prenatal Screening Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Prenatal Screening Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Prenatal Screening Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Prenatal Screening Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Prenatal Screening Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Prenatal Screening Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Prenatal Screening Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Prenatal Screening Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Prenatal Screening Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Prenatal Screening Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Prenatal Screening Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Prenatal Screening Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Prenatal Screening Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Prenatal Screening Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Prenatal Screening Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Revvity
  8. 8.2.1 Revvity Company Information
  9. 8.2.2 Revvity Business Overview
  10. 8.2.3 Revvity Prenatal Screening Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Revvity Prenatal Screening Product Portfolio
  12. 8.2.5 Revvity Recent Developments
  13. 8.3 Quest Diagnostics
  14. 8.3.1 Quest Diagnostics Company Information
  15. 8.3.2 Quest Diagnostics Business Overview
  16. 8.3.3 Quest Diagnostics Prenatal Screening Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Quest Diagnostics Prenatal Screening Product Portfolio
  18. 8.3.5 Quest Diagnostics Recent Developments
  19. 8.4 MedGenome
  20. 8.4.1 MedGenome Company Information
  21. 8.4.2 MedGenome Business Overview
  22. 8.4.3 MedGenome Prenatal Screening Revenue and Gross Margin (2021-2026)
  23. 8.4.4 MedGenome Prenatal Screening Product Portfolio
  24. 8.4.5 MedGenome Recent Developments
  25. 8.5 Mayo Clinic Laboratories
  26. 8.5.1 Mayo Clinic Laboratories Company Information
  27. 8.5.2 Mayo Clinic Laboratories Business Overview
  28. 8.5.3 Mayo Clinic Laboratories Prenatal Screening Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mayo Clinic Laboratories Prenatal Screening Product Portfolio
  30. 8.5.5 Mayo Clinic Laboratories Recent Developments
  31. 8.6 GeneDx
  32. 8.6.1 GeneDx Company Information
  33. 8.6.2 GeneDx Business Overview
  34. 8.6.3 GeneDx Prenatal Screening Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GeneDx Prenatal Screening Product Portfolio
  36. 8.6.5 GeneDx Recent Developments
  37. 8.7 PreventionGenetics
  38. 8.7.1 PreventionGenetics Company Information
  39. 8.7.2 PreventionGenetics Business Overview
  40. 8.7.3 PreventionGenetics Prenatal Screening Revenue and Gross Margin (2021-2026)
  41. 8.7.4 PreventionGenetics Prenatal Screening Product Portfolio
  42. 8.7.5 PreventionGenetics Recent Developments
  43. 8.8 SYNLAB
  44. 8.8.1 SYNLAB Company Information
  45. 8.8.2 SYNLAB Business Overview
  46. 8.8.3 SYNLAB Prenatal Screening Revenue and Gross Margin (2021-2026)
  47. 8.8.4 SYNLAB Prenatal Screening Product Portfolio
  48. 8.8.5 SYNLAB Recent Developments
  49. 8.9 Veritas Genetics
  50. 8.9.1 Veritas Genetics Company Information
  51. 8.9.2 Veritas Genetics Business Overview
  52. 8.9.3 Veritas Genetics Prenatal Screening Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Veritas Genetics Prenatal Screening Product Portfolio
  54. 8.9.5 Veritas Genetics Recent Developments
  55. 8.10 GGA
  56. 8.10.1 GGA Company Information
  57. 8.10.2 GGA Business Overview
  58. 8.10.3 GGA Prenatal Screening Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GGA Prenatal Screening Product Portfolio
  60. 8.10.5 GGA Recent Developments
  61. 8.11 Cordlife
  62. 8.11.1 Cordlife Company Information
  63. 8.11.2 Cordlife Business Overview
  64. 8.11.3 Cordlife Prenatal Screening Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Cordlife Prenatal Screening Product Portfolio
  66. 8.11.5 Cordlife Recent Developments
  67. 8.12 Rainbow Genomics
  68. 8.12.1 Rainbow Genomics Company Information
  69. 8.12.2 Rainbow Genomics Business Overview
  70. 8.12.3 Rainbow Genomics Prenatal Screening Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Rainbow Genomics Prenatal Screening Product Portfolio
  72. 8.12.5 Rainbow Genomics Recent Developments
  73. 8.13 BGI Genomics
  74. 8.13.1 BGI Genomics Company Information
  75. 8.13.2 BGI Genomics Business Overview
  76. 8.13.3 BGI Genomics Prenatal Screening Revenue and Gross Margin (2021-2026)
  77. 8.13.4 BGI Genomics Prenatal Screening Product Portfolio
  78. 8.13.5 BGI Genomics Recent Developments
  79. 8.14 Berry Genomics
  80. 8.14.1 Berry Genomics Company Information
  81. 8.14.2 Berry Genomics Business Overview
  82. 8.14.3 Berry Genomics Prenatal Screening Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Berry Genomics Prenatal Screening Product Portfolio
  84. 8.14.5 Berry Genomics Recent Developments
  85. 8.15 Annaroad
  86. 8.15.1 Annaroad Company Information
  87. 8.15.2 Annaroad Business Overview
  88. 8.15.3 Annaroad Prenatal Screening Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Annaroad Prenatal Screening Product Portfolio
  90. 8.15.5 Annaroad Recent Developments
  91. 8.16 Jiajian Medical Testing
  92. 8.16.1 Jiajian Medical Testing Company Information
  93. 8.16.2 Jiajian Medical Testing Business Overview
  94. 8.16.3 Jiajian Medical Testing Prenatal Screening Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Jiajian Medical Testing Prenatal Screening Product Portfolio
  96. 8.16.5 Jiajian Medical Testing Recent Developments
  97. 8.17 Genesky
  98. 8.17.1 Genesky Company Information
  99. 8.17.2 Genesky Business Overview
  100. 8.17.3 Genesky Prenatal Screening Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Genesky Prenatal Screening Product Portfolio
  102. 8.17.5 Genesky Recent Developments
  103. 8.18 Weihansi Biomedical Technology
  104. 8.18.1 Weihansi Biomedical Technology Company Information
  105. 8.18.2 Weihansi Biomedical Technology Business Overview
  106. 8.18.3 Weihansi Biomedical Technology Prenatal Screening Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Weihansi Biomedical Technology Prenatal Screening Product Portfolio
  108. 8.18.5 Weihansi Biomedical Technology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst